ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Microbiome startup Nextbiotix raises €7M to tackle inflammatory bowel diseases
July 09, 2018Nextbiotix has raised €7 million ($8 million) to develop a bacterial treatment for inflammatory bowel diseases. The series A round will support work to rebalance the gut microbiome through the delivery of Faecalibacterium prausnitzii, one of the most abun -
Bloom bags cash, UCLA tech to treat epilepsy via the microbiome
May 29, 2018Bloom Science has raised seed money and licensed technology to treat CNS diseases via the gut-brain axis. Building on research into the ketogenic diet, Bloom is initially focusing on developing bacterial treatments for epilepsy. -
Takeda enters into strategic collaboration with NuBiyota for Microbiome Therapeutics
April 18, 2017Takeda Pharmaceutical Company Limited announced a strategic collaboration with NuBiyota LLC for the development of Microbial Ecosystem Therapeutic products.
Pharma Sources Insight January 2025
